A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

The Parliamentary Portfolio Committee on Health has called for the decentralisation of cancer treatment facilities to district hospitals for better management of the disease. Cancer has become the ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

The Elekta Unity MR-LINAC system, used at Allegheny General Hospital, combines MRI imaging with radiation therapy to target cancerous cells with pinpoint precision.

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $17.4 billion, has announced results from its Phase 3 TALAPRO-2 study which show that a combination of ...

In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

With a new treatment for prostate cancer in play, men with more aggressive forms of prostate cancer may have a more positive ...

The primary study objective was to evaluate the prognostic value of post-therapeutic SPECT by RECIP 1.0 for overall survival.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.